about
Mutational signatures of ionizing radiation in second malignanciesCase report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapiesAngioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric CancerInhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial CellsCombined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgraftsClonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytesFrequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.High-Throughput Identification of Adaptive Mutations in Experimentally Evolved Yeast Populations.Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in TaiwanPhosphotyrosine phosphatase R3 receptors: Origin, evolution and structural diversificationImplementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathwayPhospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.Adenoma development in familial adenomatous polyposis and MUTYH-associated polyposis: somatic landscape and driver genes.Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential.miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.Recurrently deregulated lncRNAs in hepatocellular carcinoma.R3 receptor tyrosine phosphatases: conserved regulators of receptor tyrosine kinase signaling and tubular organ development.Genetic alterations of protein tyrosine phosphatases in human cancers.Receptor-type protein tyrosine phosphatases in cancer.Angiosarcoma: A rare malignancy with protean clinical presentations.Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.The role of phospholipase Cγ1 in breast cancer and its clinical significance.Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes.Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside StudyMolecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.Therapeutic targeting of the angiopoietin-TIE pathway.Molecular profiling of sarcomas: new vistas for precision medicine.Protein tyrosine phosphatase PTPRB regulates Src phosphorylation and tumour progression in NSCLC.A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRASRecurrent GNAQ mutations in anastomosing hemangiomas.The receptor protein tyrosine phosphatase PTPRB negatively regulates FGF2-dependent branching morphogenesis.Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update.Integrative analysis to identify oncogenic gene expression changes associated with copy number variations of enhancer in ovarian cancer.
P2860
Q28389573-23B11CDB-05FA-48B2-A178-F05EB715C583Q30834078-E049B166-C85A-4374-B36D-16C9AA76BCD4Q33566663-7CC460E8-3348-47BD-81C5-AD1741AE4A8EQ33850534-B9C1BE54-0961-4912-B06E-B69436DD7B63Q34677333-7AA48827-5399-4AC6-8FF0-6D398A5B98BCQ35407284-6028468F-A2EC-4AF6-8141-8C3EB09C2711Q35751343-92F01491-5049-4A1D-9F05-249423906ED6Q35752316-F8ACD8AE-115A-4F30-8FDD-D65C6586FDB2Q35798540-50369E88-45FF-4A71-AF88-4EDEC5113D4AQ35832675-3B1687AA-E686-481D-BC09-133D10EB2EFFQ36054323-B53E08A5-7740-40EE-B6F2-0DE2CCD15A2AQ36160359-28964EEF-ED23-490F-B3C5-B7910CE0B224Q36195676-EC6416F5-8859-4FDF-BBA5-C524C6D38C71Q36296518-8DC11290-1E1C-4AA3-A52B-4E787892B013Q36408417-62B185A6-B65E-4974-8860-5E18CEDF0DF1Q36546559-AA28EA69-9DB3-4E31-BD77-64192B8740BCQ36546673-FCC18ED8-CB9B-43BD-B625-E3F289C58CBAQ36800004-C3B74E83-9D7B-44D6-AFC1-80B08A47A555Q36803294-0B7F841D-D35B-4E1B-A3B1-5AA43D01B05AQ36873834-343C7544-C592-4A74-9194-B4D41307E04BQ37591905-6A8A4FB0-1DDF-45B4-A59C-48F686C0F5D1Q37628996-85B89752-9BF1-423F-9AAB-4ED0A5A94083Q37651849-6894EC87-68DF-4862-9486-CE234D7C6033Q38252989-6421FB03-B441-4D48-9E2D-E1331282AFD2Q38255066-FAE29067-3567-4CFD-9203-A5280FED7A1CQ38260826-85D5662D-2E90-4938-B566-F91B3B79EC78Q38510830-E5A4D6DE-1B11-4812-A348-62EFC8083138Q38625070-565A8E27-41CD-4BFC-B3F5-9ED91E15549EQ38638852-3A9300E5-81BA-4D26-8780-164427D3462BQ38648597-59B52EA6-7700-43B1-817A-B537DE51A0D6Q38769283-9A7501CF-94B7-4ED9-BE0B-C5DD94363E4AQ38927569-A71B822B-5B15-47AE-BAC6-B54EA950D1FCQ39321127-F7F8A45B-114B-4DB1-8DC4-43614C37A825Q39406356-BE2FD4D9-750C-476B-9325-1575D647F7D8Q40695460-9A7DA39B-BFDA-4F69-A6B3-EE48AE8640E6Q42315014-6BA51442-B1DE-475D-ABA0-54B36D9434DDQ46195454-6099DD67-24DD-4A75-A741-FAFE09A9FC7BQ46312279-3B0EE009-0F92-412C-9B4B-DCB9BC74F4ACQ47122078-219079E7-A89D-477B-8763-E6455E1BB92BQ47124134-71A4F04B-5912-415B-BC7C-C5A7BDEEB5FF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@ast
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@en
type
label
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@ast
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@en
prefLabel
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@ast
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
@en
P2093
Adam Butler
Adrienne M Flanagan
Alexei Protopopov
Bhavisha Khatri
Chris Boshoff
Claire Hardy
Curtis Gumbs
Daniel Baumhoer
Davis Ingram
Dina Halai
P2860
P2888
P304
P356
10.1038/NG.2921
P407
P50
P577
2014-03-16T00:00:00Z